22-23766101-C-G
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_213720.3(CHCHD10):c.409+27G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.812 in 1,612,866 control chromosomes in the GnomAD database, including 535,704 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.80 ( 48697 hom., cov: 31)
Exomes 𝑓: 0.81 ( 487007 hom. )
Consequence
CHCHD10
NM_213720.3 intron
NM_213720.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.95
Genes affected
CHCHD10 (HGNC:15559): (coiled-coil-helix-coiled-coil-helix domain containing 10) This gene encodes a mitochondrial protein that is enriched at cristae junctions in the intermembrane space. It may play a role in cristae morphology maintenance or oxidative phosphorylation. Mutations in this gene cause frontotemporal dementia and/or amyotrophic lateral sclerosis-2. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 7 and 19. [provided by RefSeq, Aug 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 22-23766101-C-G is Benign according to our data. Variant chr22-23766101-C-G is described in ClinVar as [Benign]. Clinvar id is 1209687.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.825 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CHCHD10 | NM_213720.3 | c.409+27G>C | intron_variant | ENST00000484558.3 | NP_998885.1 | |||
CHCHD10 | NM_001301339.2 | c.430+27G>C | intron_variant | NP_001288268.1 | ||||
CHCHD10 | NR_125755.2 | n.454+27G>C | intron_variant | |||||
CHCHD10 | NR_125756.2 | n.287+27G>C | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CHCHD10 | ENST00000484558.3 | c.409+27G>C | intron_variant | 1 | NM_213720.3 | ENSP00000418428.3 |
Frequencies
GnomAD3 genomes AF: 0.798 AC: 121268AN: 151934Hom.: 48681 Cov.: 31
GnomAD3 genomes
AF:
AC:
121268
AN:
151934
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.781 AC: 193796AN: 248202Hom.: 76624 AF XY: 0.775 AC XY: 104306AN XY: 134570
GnomAD3 exomes
AF:
AC:
193796
AN:
248202
Hom.:
AF XY:
AC XY:
104306
AN XY:
134570
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.814 AC: 1188716AN: 1460814Hom.: 487007 Cov.: 69 AF XY: 0.808 AC XY: 587139AN XY: 726624
GnomAD4 exome
AF:
AC:
1188716
AN:
1460814
Hom.:
Cov.:
69
AF XY:
AC XY:
587139
AN XY:
726624
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.798 AC: 121324AN: 152052Hom.: 48697 Cov.: 31 AF XY: 0.793 AC XY: 58945AN XY: 74332
GnomAD4 genome
AF:
AC:
121324
AN:
152052
Hom.:
Cov.:
31
AF XY:
AC XY:
58945
AN XY:
74332
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2255
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 03, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Frontotemporal dementia and/or amyotrophic lateral sclerosis 2 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 22, 2021 | - - |
Lower motor neuron syndrome with late-adult onset Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 22, 2021 | - - |
Autosomal dominant mitochondrial myopathy with exercise intolerance Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 22, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at